This study aims to evaluate the long-term outcomes of perampanel treatment in patients with primary orthostatic tremor.
Cohort study design focusing on patients with primary orthostatic tremor
Assessment of treatment continuation and clinical outcomes over time
Monitoring of adverse effects related to perampanel usage
Continued use of perampanel linked to improved clinical outcomes in approximately 50% of patients
Long-term benefits observed despite the presence of persistent adverse effects
Abstract
In around half of patients, continued use of perampanel is associated with better clinical outcomes, also on the long term, but adverse effects are common and persistent.